Inhibiting FOXM1 Sensitizes Myeloma Cells to BCL2 Inhibitor Venetoclax By Repressing MYC Pathway

被引：2

作者：

Zhou, Vivian ^{[1
]}

Bachelor, Luke Moat ^{[2
]}

Yu, Manya ^{[1
]}

Parashar, Deepak ^{[1
]}

Shour, Abdul ^{[3
]}

Zhang, Liang ^{[1
]}

Kitchner, Terrie ^{[3
,5
,6
]}

Shukla, Sanjay ^{[3
]}

Guo, Song ^{[4
]}

Ananiev, Gene ^{[4
]}

Katzenellenbogen, Benita S.

Katzenellenbogen, John ^{[7
]}

Onitilo, Adedayo ^{[8
]}

Janz, Siegfried ^{[1
]}

Wen, Zhi ^{[2
]}

机构：

[1] Med Coll Wisconsin, Milwaukee, WI USA

[2] Marshfield Clin Res Inst, Ctr Precis Med Res, Marshfield, WI USA

[3] Marshfield Clin Res Inst, Marshfield, WI USA

[4] Univ Wisconsin Madison, Madison, WI USA

[5] Univ Illinois, Dept Physiol, Ctr Canc, Urbana, IL USA

[6] Univ Illinois, Dept Chem, Ctr Canc, Urbana, IL USA

[7] Univ Illinois, Dept Physiol & Chem, Ctr Canc, Urbana, IL USA

[8] Marshfield Clin Res Fdn, Canc Care & Res Ctr, Marshfield, WI USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180268

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy
Pandit, Bulbul
Gartel, Andrei L.
CELL CYCLE, 2011, 10 (19) : 3269 - 3273
[2] Synergistic effect of FOXM1 and BCL-2 inhibition in a preclinical treatment study on multiple myeloma
Zhou, Vivian
Yu, Manya
Fu, Jiaqi
Janz, Siegfried
Cui, Xing
JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
[3] Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors
Juarez, Dennis
Buono, Roberta
Matulis, Shannon M.
Gupta, Vikas A.
Duong, Madeleine
Yudiono, Jacob
Paul, Madhuri
Mallya, Sharmila
Diep, Grace
Hsin, Peter
Lu, Alexander
Suh, Sang Mi
Dong, Vy M.
Roberts, Andrew W.
Leverson, Joel D.
Jalaluddin, Muhammad
Liu, Zhuangzhuang
Bueno, Orlando F.
Boise, Lawrence H.
Fruman, David A.
CANCER RESEARCH COMMUNICATIONS, 2023, 3 (12): : 2497 - 2509
[4] IGLL5-BCL2L1 Rearrangement with Loss of BCL2 Dependency As Mechanism of Venetoclax Resistance in Multiple Myeloma (MM)
Alberge, Jean-Baptiste
Sinha, Sarthak
Maity, Ranjan
Jaffer, Arzina
Donovan, Justin
Kong, Madison
Minvielle, Stephane
Neri, Paola
Bahlis, Nizar
BLOOD, 2019, 134
[5] Statins Enhance Killing of Multiple Myeloma Cells By the BCL-2 Inhibitor Venetoclax and the MCL-1 Inhibitor S63845
Fruman, David
Juarez, Dennis
Diep, Grace
Nguyen, Falisha
Gupta, Vikas A.
Boise, Lawrence H.
BLOOD, 2019, 134
[6] NEK2 Promotes ESCC Malignant Progression by Inhibiting Cellular Senescence via the FOXM1/c-Myc/p27 Signaling Pathway
Li, Jiachen
Wang, Yaojie
Wei, Sisi
Xu, Shi
Dai, Suli
Zhang, Li
Tian, Ziqiang
Zhao, Lianmei
Lv, Huilai
MOLECULAR CARCINOGENESIS, 2024,
[7] Evaluating the effects of Bcl2 inhibitor, venetoclax, on cellular growth and clustering in triple-negative breast cancer cells
Ruiz, Alexis Jordan
Park, Nicolas
Abdulkareem, Noor
Trivedi, Meghna
CANCER RESEARCH, 2023, 83 (07)
[8] Inhibition of EZH2 and activation of ERRγ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway
Huang, Boyan
Mu, Peiqiang
Yu, Yan
Zhu, Wenya
Jiang, Tianqing
Deng, Rong
Feng, Gongkan
Wen, Jikai
Zhu, Xiaofeng
Deng, Yiqun
GASTRIC CANCER, 2021, 24 (01) : 72 - 84
[9] Inhibition of EZH2 and activation of ERRγ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway
Boyan Huang
Peiqiang Mu
Yan Yu
Wenya Zhu
Tianqing Jiang
Rong Deng
Gongkan Feng
Jikai Wen
Xiaofeng Zhu
Yiqun Deng
Gastric Cancer, 2021, 24 : 72 - 84
[10] STROMA-DERIVED FACTORS STIMULATE JAK/STAT SIGNALING IN AML CELLS RESULTING IN RESISTANCE TO BCL2 INHIBITOR VENETOCLAX
Karjalainen, R.
Popa, M.
Liu, M.
Javarappa, K. K.
Kontro, M.
Parsons, A.
Porkka, K.
Wennerberg, K.
McCormack, E.
Gjertsen, B. T.
Heckman, C. A.
HAEMATOLOGICA, 2017, 102 : 39 - 39

← 1 2 3 4 5 →